Pharmaron Beijing Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SHSC:3759 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
10 Oct 24	SellHK$73,202,725	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	4,483,263	HK$16.33
09 Oct 24	BuyHK$6,954,589	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	418,941	HK$16.60
06 Mar 24	SellHK$9,179,456	Mitsubishi UFJ Morgan Stanley Securities Co., Ltd., Securities & Investments Arm	Company	796,109	HK$11.53
06 Mar 24	SellHK$2,685,200	Morgan Stanley, Investment Banking and Brokerage Investments	Company	232,880	HK$11.53
05 Feb 24	SellHK$667,235	JP Morgan Asset Management	Company	72,300	HK$9.23
05 Feb 24	SellHK$45,294	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	4,908	HK$9.23
02 Feb 24	BuyHK$9,198,468	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	994,343	HK$9.25
31 Jan 24	SellHK$4,549,994	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	441,250	HK$10.31
29 Jan 24	BuyHK$22,894,335	JPMorgan Chase & Co, Brokerage and Securities Investments	Company	2,106,893	HK$10.87

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 3759?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	138,457,062	7.79%
Private Companies	205,877,591	11.6%
VC/PE Firms	289,326,500	16.3%
General Public	377,002,829	21.2%
Institutions	767,122,027	43.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 74.55% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
17.2%	CITIC Securities Company Limited, Asset Management Arm	305,326,464	HK$7.3b	0%	9.03%
16.3%	Citic M&A Fund Management Co., Ltd.	289,326,500	HK$6.9b	-5.24%	100.0%
10.2%	Pharmaron Holdings Limited	180,496,500	HK$4.3b	0%	no data
5.66%	Xiaoqiang Lou	100,675,076	HK$2.4b	0%	no data
5.66%	Zhong Ou Fund Management Co., Ltd	100,561,886	HK$2.4b	8.66%	1.37%
2.65%	E Fund Management Co., Ltd.	47,033,214	HK$1.1b	0%	0.18%
2.12%	Bei Zheng	37,706,986	HK$898.8m	0%	no data
1.68%	Hwabao WP Fund Management Co., Ltd	29,950,461	HK$713.9m	7.52%	0.68%
1.32%	Beijing Legend Tongdao Investment Consulting Partnership Enterprise (Limited Partnership)	23,535,557	HK$561.0m	0%	98.92%
1.15%	China Merchants Fund Management Company Ltd.	20,508,077	HK$488.8m	0%	0.3%
1.13%	GF Fund Management Co., Ltd.	20,118,752	HK$479.5m	0%	0.13%
1.08%	China Universal Asset Management Company Ltd.	19,224,221	HK$458.2m	0%	0.16%
0.94%	Fullgoal Fund Management Co. Ltd.	16,792,956	HK$400.3m	0%	0.14%
0.87%	Huatai-PineBridge Fund Management Co., Ltd.	15,398,934	HK$367.0m	0%	0.08%
0.86%	The Vanguard Group, Inc.	15,345,628	HK$365.8m	0.92%	no data
0.85%	HSBC Jintrust Fund Management Company Limited	15,059,200	HK$358.9m	0%	1.09%
0.82%	HuaAn Fund Management Company Ltd.	14,616,497	HK$348.4m	0%	0.2%
0.8%	Tianhong Asset Management Co., Ltd.	14,171,901	HK$337.8m	0%	0.24%
0.7%	China Asset Management Co. Ltd.	12,437,835	HK$296.5m	-0.01%	0.04%
0.67%	BlackRock, Inc.	11,862,102	HK$282.7m	2.85%	no data
0.5%	Yinhua Fund Management Co., Ltd.	8,815,054	HK$210.1m	0%	0.19%
0.46%	JPMorgan Chase & Co, Brokerage and Securities Investments	8,119,141	HK$193.5m	-6.86%	0.01%
0.42%	Harvest Fund Management Co. Ltd.	7,428,100	HK$177.1m	0%	0.06%
0.31%	Bosera Asset Management Co., Ltd.	5,546,536	HK$132.2m	0%	0.04%
0.3%	Xiamen Longtai Huisheng Enterprise Management Partnership Enterprise (Limited Partnership)	5,261,858	HK$125.4m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/08 00:13
End of Day Share Price	2025/01/08 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Pharmaron Beijing Co., Ltd. is covered by 26 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Linda Lu	BOCI Research Ltd.
Yang Luo	BOCI Research Ltd.
Bo Li	BofA Global Research